U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Waf-1 (p21) and p53 Polymorphisms in Breast Cancer

Public Domain


Details

  • Personal Author:
  • Description:
    p53 is a transcription factor for Waf-1/p21, a cyclin-dependent kinase inhibitor. Certain polymorphic variants of Waf-1 and p53 have been evaluated for their association with cancer risk. Previous studies indicated that certain p53 polymorphisms confer an increased risk of breast cancer [odds ratios (ORs) and 95% confidence intervals (CIs) = 2.9, 1.4-6.3 Carcinogenesis (Lond.), 17: 1313, 1996; 2.5, 1.3-4.8 Cancer Epidemiol. Biomark. Prev., 6: 105, 1997; and 1.5, 1.1-2.0, Anticancer Res., 18: 2095, 1998). The primary objectives of this study were to test the hypotheses that the serine variant (codon 31 polymorphism) of Waf-1 is also involved in this process and that there is an interaction between Waf-1 and p53 polymorphisms. To do this, Waf-1 and p53 genotypes were determined for women enrolled in a breast cancer case-control study (Caucasians, African-Americans and Latinas; 487 Waf-1 and 504 p53 genotypes were obtained). Multivariate logistic regression was used to evaluate possible associations between Waf-1 and p53 polymorphisms, race, and menopause. The primary aim was to determine whether an interaction between Waf-1 and p53(1-2-1) existed. Whereas multivariate analysis suggested associations between breast cancer and inheritance of Waf-1ser31 in African-Americans (OR, 2.32; 95% CI = 0.66-5.60; n = 37 cases and 65 controls) and Latinas (OR, 2.22; 95% CI = 0.71-6.89; n = 30 cases and 75 controls), and inheritance of p53(1-2-1) in Caucasians (OR, 3.15; 95% CI = 1.14-8.89; n = 93 cases and 187 controls), we did not see an interaction between Waf-1(ser31) and p53(1-2-1). Consistent with the finding that p531(1-2-1) is a risk factor for Caucasian women was the observation of a strong interaction between race and p53 (P < 0.01). [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    1055-9965
  • Document Type:
  • Genre:
  • Place as Subject:
  • CIO:
  • Division:
  • Topic:
  • Location:
  • Pages in Document:
    127-130
  • Volume:
    11
  • Issue:
    1
  • NIOSHTIC Number:
    nn:20022906
  • Citation:
    Cancer Epidemiol Biomark Prev 2002 Jan; 11(1):127-130
  • Contact Point Address:
    National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, MS-L3014, 1095 Willowdale Road, Morgantown, WV 26505-2888
  • Email:
    agw8@cdc.gov
  • Federal Fiscal Year:
    2002
  • NORA Priority Area:
  • Peer Reviewed:
    True
  • Source Full Name:
    Cancer Epidemiology, Biomarkers & Prevention
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:31259339c80a66d5778d61916b7565ec27ee9adf87d8217f21ee86a341f6050fb0a117c375a0723628c93f570d138706a0519f107803ccc73a28c6a61f17fcfe
  • Download URL:
  • File Type:
    Filetype[PDF - 173.18 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.